{
 "drug": "Nitroglycerin Ointment",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "04/14/2026",
 "dayN": 133,
 "cat": "Analgesia/Addiction",
 "companies": [
  "AbbVie Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "04/14/2026",
   "update_type": "New",
   "initial_posting_date": "04/14/2026",
   "package_ndc": "58914-301-80",
   "generic_name": "Nitroglycerin Ointment",
   "contact_info": "800-678-1605",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA021359"
    ],
    "brand_name": [
     "RECTIV"
    ],
    "generic_name": [
     "NITROGLYCERIN"
    ],
    "manufacturer_name": [
     "Allergan, Inc."
    ],
    "product_ndc": [
     "58914-301"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RECTAL"
    ],
    "substance_name": [
     "NITROGLYCERIN"
    ],
    "rxcui": [
     "1114466",
     "1114470"
    ],
    "spl_id": [
     "a2f0ef5a-c3b6-4330-9b33-131369431ddd"
    ],
    "spl_set_id": [
     "603aa9ed-54c4-4a35-ade4-690fa44850e4"
    ],
    "package_ndc": [
     "58914-301-80",
     "58914-301-85"
    ],
    "nui": [
     "N0000175415",
     "M0014874",
     "N0000009909"
    ],
    "pharm_class_epc": [
     "Nitrate Vasodilator [EPC]"
    ],
    "pharm_class_cs": [
     "Nitrates [CS]"
    ],
    "pharm_class_pe": [
     "Vasodilation [PE]"
    ],
    "unii": [
     "G59M7S0WS3"
    ]
   },
   "update_date": "04/14/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Ointment",
   "presentation": "Rectiv, Ointment, 0.4% (NDC 58914-301-80)",
   "company_name": "AbbVie Inc.",
   "status": "To Be Discontinued"
  }
 ]
}